Trial Profile
Empiric Treatment for Suspected Acute HIV Infection in the Emergency Department
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2023
Price :
$35
*
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms EMTreatED
- 24 Apr 2023 Planned End Date changed from 1 Oct 2021 to 1 Jun 2023.
- 24 Apr 2023 Planned primary completion date changed from 1 Apr 2021 to 1 Jun 2023.
- 24 Apr 2023 Status changed from recruiting to active, no longer recruiting.